Abstract
Background
Since the 1950s, preoperative medical preparation has been widely applied in patients with pheochromocytoma to improve intraoperative hemodynamic instability and postoperative complications. However, advancements in preoperative imaging, laparoscopic surgical techniques, and anesthesia have considerably improved management in patients with pheochromocytoma. In consequence, there is no validated consensus on current predictive factors for postoperative morbidity. The aim of this study was to determine perioperative factors which are predictive for postoperative morbidity in patients undergoing laparoscopic adrenalectomy for pheochromocytoma.
Study design
It is a retrospective analysis of prospectively maintained databases in five medical centers from 2002 to 2013. Inclusion criteria were consecutive patients who underwent non-converted laparoscopic unilateral total adrenalectomy for pheochromocytoma.
Results
Two-hundred and twenty-five patients were included. All-cause and cardiovascular postoperative morbidity rates were 16 % (n = 36) and 4.8 % (n = 11), respectively. Preinduction blood pressure normalization after preoperative medical preparation had no impact on postoperative morbidity. However, past medical history of coronary artery disease (OR [CI95 %] = 3.39; [1.317–8.727]) and incidence of intraoperative hemodynamic instability episodes (both SBP ≥ 160 mmHg and MAP < 60 mmHg) (OR [CI95 %] = 3.092; [1.451–6.587]) remained independent predictors for postoperative all-cause morbidity. Similarly, past medical history of coronary artery disease (OR [CI95 %] = 14.41; [3.119–66.57]), female sex (OR [CI95 %] = 12.05; [1.807–80.31]), and incidence of intraoperative hemodynamic instability episodes (both SBP ≥ 200 mmHg and MAP < 60 mmHg) (OR [CI95 %] = 4.13; [1.009–16.90]) remained independent predictors for postoperative cardiovascular morbidity.
Conclusions
This study identifies risk factors for cardiovascular and all-cause postoperative morbidity after laparoscopic adrenalectomy in current clinical setting. These data can help physicians to guide intra-operative blood pressure management and have to be taken into account in further studies.
Similar content being viewed by others
References
Kercher K, Novitsky Y, Park A, Matthews B, Litwin D, Heniford B (2005) Laparoscopic resection in pheochromocytomas. Ann Surg 241:919–926
Duh QY (2001) Evolving surgical management for patients with pheochromocytoma. J Clin Endocrinol Metab 86:1477–1479
Lentschener C, Gaujoux S, Tesniere A, Dousset B (2011) Point of controversy: perioperative care of patients undergoing pheochromocytoma removal—time for reappraisal ? Eur J Endocrinol 165:365–373
Bruynzeel H, Feelders R, Groenland TH, Van der Meiracker A, Van Eijck C, Lange J et al (2010) Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab 95:678–685
Kierman CM, Du L, Chen X, Broome JT, Chanjuan S, Peters MF, et al (2014) Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol. Published online 18 June 2014. doi 10.1245/s10434-014-3847-7
Siddiqi H, Yang H, Laird A, Fox A, Doherty G, Miller B et al (2012) Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas. Surgery. 152:1027–1036
Kinney M, Narr BJ, Warmer MA (2002) Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 16:359–369
Kvale WF, Roth GM, Manger WM, Priestley JT (1956) Pheochromocytoma. Circulation 14:622–630
Roizen MF, Schreider BD, Hassan SZ (1987) Anesthesia for patients with pheochromocytoma. Anesthesiol Clin North Am 5:269–275
Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915–1942
Combemale F, Carnaille B, Tavernier B, Hautier M, Thevenot A, Scherpereel P et al (1998) Exclusive use of calcium channel blockers and cardioselective beta-blockers in the pre- and per-operative management of pheochromocytomas. Ann Chir 52:341–345
Brunaud L, Boutami M, Nguyen PL, Finnerty B, Germain A, Weryha G et al (2014) Both preoperative Alpha and Calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery 156:1410–1418
Weingarten T, Cata J, O’Hara J, Prybilla D, Pike T, Thompson G et al (2010) Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 76:e6–e11
Lebuffe G, Dosseh D, Tek G, Tytgat H, Moreno S, Tavernier B et al (2005) The effect of calcium channel blockers on outcome following the surgical treatment of phaechromocytomas and paragangliomas. Anesthesia 60:439–444
Inabnet WB, Pitre J, Bernard D, Chapuis Y (2000) Comparison of the hemodynamic parameters of open and laparoscopic adrenalectomy for pheochromocytoma. World J Surg 24:574–578
Sprung J, O’Hara JF Jr, Gill IS, Abdelmalak B, Sarnaik A (2000) EL. B. Anesthetic aspects of laparoscopic and open adrenalectomy for pheochromocytoma. Urology 55:339–343
Scholten A, Vriens M, Cromheecke G, Rinkes IH, Valk GD (2011) Hemodynamic instability during resection of pheochromocytoma in MEN versus non-NEM patients. Eur J Endocrinol 165:91–96
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications. Ann Surg 240:205–213
Kazic MR, Zivaljevic VR, Milan ZB, Paunovic IR (2011) Perioperative risk factors, morbidity, and outcomes of 145 patients during phaeochromocytoma resection. Acta Chir Belg 111:223–227
Dickson P, Alex G, Grubbs E, Ayala-Ramirez M, Jimenez C, Evans D et al (2011) Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery 150:452–458
Lang B, Fu B, Ouyang JZ, Wang B, Zhang G, Xu K et al (2008) Retrospective comparison of retroperitoneoscopic versus open adrenalectomy for pheochromocytoma. J Urol 179:57–60
Stolk R, Bakx C, Mulder J, Timmers H, Lenders JW (2013) Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines? J Clin Endocrinol Metab 98:1100–1106
Solozarno CC, Lew JL, Wilhelm S, Sumner W, Huang W, Wu W et al (2007) Outcomes of pheochromocytoma management in the laparoscopic era. Ann Surg Oncol 14:3004–3010
Zhang X, Lang B, Ouyang JZ, Fu B, Zhang J, Xu K et al (2007) Retroperitoneoscopic adrenalectomy without previous control of adrenal vein is feasible and safe for pheochromocytoma. Urology 69:849–853
Walz M, Alesina P, Wenger F, Koch J, Neumann H, Petersenn S et al (2006) Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paraganglioma: results of 161 tumors in 126 patients. World J Surg 30:899–908
Shen W, Grogan R, Vriens M, Clark O, Duh QY (2010) One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy. Arch Surg 145:893–897
Lentschener C, Gaujoux S, Thillois JM, Duboc D, Bertherat J, Ozier Y et al (2009) Increased arterial pressure is not predictive of haemodynamic instability in patients undergoing adrenalectomy for phaechromocytoma. Acta Anaesthesiol Scand 53:522–527
Disclosures
Brunaud, Nguyen-Thi, Mirallie, Raffaelli, Vriens, Theveniaud, Boutami, Finnerty, Vorselaars, Borel Rinkes, Bellantone, Lombardi, Fahey, Zarnegar, and Bresler have no conflict of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brunaud, L., Nguyen-Thi, PL., Mirallie, E. et al. Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients. Surg Endosc 30, 1051–1059 (2016). https://doi.org/10.1007/s00464-015-4294-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-015-4294-7